Health system costs of providing outpatient care for diabetes in people with TB in the Philippines

T. Yamanaka, M. C. Castro, J.P. Ferrer, J. A. Solon, S. E. Cox, Y. V. Laurence, A. Vassall
{"title":"Health system costs of providing outpatient care for diabetes in people with TB in the Philippines","authors":"T. Yamanaka, M. C. Castro, J.P. Ferrer, J. A. Solon, S. E. Cox, Y. V. Laurence, A. Vassall","doi":"10.5588/ijtldopen.23.0554","DOIUrl":null,"url":null,"abstract":"BACKGROUNDDiabetes mellitus (DM) is a known risk factor for active TB. A key activity in the Philippines is to integrate TB services with other disease programmes, with a target of DM screening in 90% of TB cases. However, costs of providing\n DM outpatient services for TB patients are not well known.METHODSWe estimated the costs of providing integrated DM outpatient services within TB services from the health system perspective. Resources for outpatient DM services were valued\n using the bottom-up approach for capital goods, staff time and consumables. Resource quantities were obtained by interviewing 60 healthcare professionals in 11 health facilities in the Philippines.RESULTSThe mean cost per service ranged\n from USD0.53 for DM risk assessment to USD23.72 for oral glucose tolerance test. The cost per case detected for different algorithms varied from USD17.43 to USD80.81. The monthly cost per patient was estimated at USD8.95 to USD12.36.CONCLUSIONOur\n study provides the first estimates of costs for providing integrated DM outpatient services and TB care in a low- and middle-income country. The costs of DM detection in TB patients suggests that it may be useful to further investigate the cost-effectiveness and affordability of service delivery.","PeriodicalId":516613,"journal":{"name":"IJTLD OPEN","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJTLD OPEN","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/ijtldopen.23.0554","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUNDDiabetes mellitus (DM) is a known risk factor for active TB. A key activity in the Philippines is to integrate TB services with other disease programmes, with a target of DM screening in 90% of TB cases. However, costs of providing DM outpatient services for TB patients are not well known.METHODSWe estimated the costs of providing integrated DM outpatient services within TB services from the health system perspective. Resources for outpatient DM services were valued using the bottom-up approach for capital goods, staff time and consumables. Resource quantities were obtained by interviewing 60 healthcare professionals in 11 health facilities in the Philippines.RESULTSThe mean cost per service ranged from USD0.53 for DM risk assessment to USD23.72 for oral glucose tolerance test. The cost per case detected for different algorithms varied from USD17.43 to USD80.81. The monthly cost per patient was estimated at USD8.95 to USD12.36.CONCLUSIONOur study provides the first estimates of costs for providing integrated DM outpatient services and TB care in a low- and middle-income country. The costs of DM detection in TB patients suggests that it may be useful to further investigate the cost-effectiveness and affordability of service delivery.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
菲律宾结核病患者糖尿病门诊治疗的卫生系统成本
背景糖尿病(DM)是活动性肺结核的一个已知风险因素。菲律宾的一项重要活动是将结核病服务与其他疾病项目相结合,目标是对 90% 的结核病病例进行糖尿病筛查。我们从卫生系统的角度估算了在结核病服务中提供综合糖尿病门诊服务的成本。我们采用自下而上的方法,对资本货物、员工时间和消耗品进行了估价。结果每次服务的平均成本从 DM 风险评估的 0.53 美元到口服葡萄糖耐量试验的 23.72 美元不等。不同算法检测到的每个病例的成本从 17.43 美元到 80.81 美元不等。我们的研究首次估算了中低收入国家提供综合 DM 门诊服务和结核病护理的成本。肺结核患者的 DM 检测成本表明,进一步调查提供服务的成本效益和可负担性可能是有益的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines Evaluation of a national multidisciplinary meeting for non-tuberculous mycobacterial disease Leveraging Global Fund’s investments to expand innovative public-private provider engagement in TB Real-life use of delamanid: results from the European post-authorisation safety study Embracing novel thinking to safeguard against airborne pathogens in indoor spaces
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1